Skip to Main Content
Skip Nav Destination

Translational Studies Using the MALT1 Inhibitor (S)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer

Journal of Immunotherapy and Precision Oncology (2023) 6 (2): 61–73.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Asmaa F. Khafaga
  • Mohamed M.S. Gaballa
  • Reham Karam
  • Salma A. Shoulah
  • Rehab N. Shamma
  • Norhan E. Khalifa
  • Nehal E. Farrag
  • Ahmed E. Noreldin
Life Sciences (2024) 341: 122499.
  • Iliana K. Kerzeli
  • Aikaterini Nasi
  • Erika Fletcher
  • Aikaterini Chourlia
  • Anders Kallin
  • Niklas Finnberg
  • Karolina Ersmark
  • Maria Lampinen
  • Mark Albertella
  • Fredrik Öberg
  • Sara M. Mangsbo
Cellular Immunology (2024) 397-398: 104814.
  • Jinming Liu
  • Biao Zhang
  • Guolin Zhang
  • Dong Shang
Frontiers in Immunology (2024) 15
  • Thomas J. O'Neill
  • Marie J. Tofaute
  • Daniel Krappmann
Cancer Treatment Reviews (2023) 117: 102568.
Close Modal

or Create an Account

Close Modal
Close Modal